These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19928753)

  • 1. The effect of ligand-based tautomer and protomer prediction on structure-based virtual screening.
    Kalliokoski T; Salo HS; Lahtela-Kakkonen M; Poso A
    J Chem Inf Model; 2009 Dec; 49(12):2742-8. PubMed ID: 19928753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of protonation, tautomeric, and stereoisomeric states on protein-ligand docking results.
    ten Brink T; Exner TE
    J Chem Inf Model; 2009 Jun; 49(6):1535-46. PubMed ID: 19453150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of several molecular docking programs: pose prediction and virtual screening accuracy.
    Cross JB; Thompson DC; Rai BK; Baber JC; Fan KY; Hu Y; Humblet C
    J Chem Inf Model; 2009 Jun; 49(6):1455-74. PubMed ID: 19476350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tautomer preference in PDB complexes and its impact on structure-based drug discovery.
    Milletti F; Vulpetti A
    J Chem Inf Model; 2010 Jun; 50(6):1062-74. PubMed ID: 20515065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in compound database preparation--"hidden" impact on virtual screening results.
    Knox AJ; Meegan MJ; Carta G; Lloyd DG
    J Chem Inf Model; 2005; 45(6):1908-19. PubMed ID: 16309298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient virtual screening using multiple protein conformations described as negative images of the ligand-binding site.
    Virtanen SI; Pentikäinen OT
    J Chem Inf Model; 2010 Jun; 50(6):1005-11. PubMed ID: 20504004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening and prediction of site of metabolism for cytochrome P450 1A2 ligands.
    Vasanthanathan P; Hritz J; Taboureau O; Olsen L; Jørgensen FS; Vermeulen NP; Oostenbrink C
    J Chem Inf Model; 2009 Jan; 49(1):43-52. PubMed ID: 19099399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of ligand protonation on virtual screening against beta-secretase (BACE1).
    Polgar T; Magyar C; Simon I; Keserü GM
    J Chem Inf Model; 2007; 47(6):2366-73. PubMed ID: 17944457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating virtual screening in lead discovery.
    Oprea TI; Matter H
    Curr Opin Chem Biol; 2004 Aug; 8(4):349-58. PubMed ID: 15288243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LigMatch: a multiple structure-based ligand matching method for 3D virtual screening.
    Kinnings SL; Jackson RM
    J Chem Inf Model; 2009 Sep; 49(9):2056-66. PubMed ID: 19685924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epik: a software program for pK( a ) prediction and protonation state generation for drug-like molecules.
    Shelley JC; Cholleti A; Frye LL; Greenwood JR; Timlin MR; Uchimaya M
    J Comput Aided Mol Des; 2007 Dec; 21(12):681-91. PubMed ID: 17899391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of tautomer forms on pharmacophore-based virtual screening.
    Oellien F; Cramer J; Beyer C; Ihlenfeldt WD; Selzer PM
    J Chem Inf Model; 2006; 46(6):2342-54. PubMed ID: 17125178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand-target interaction-based weighting of substructures for virtual screening.
    Crisman TJ; Sisay MT; Bajorath J
    J Chem Inf Model; 2008 Oct; 48(10):1955-64. PubMed ID: 18821751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of 3D virtual ligand screening methods: impact of the molecular alignment on enrichment.
    Giganti D; Guillemain H; Spadoni JL; Nilges M; Zagury JF; Montes M
    J Chem Inf Model; 2010 Jun; 50(6):992-1004. PubMed ID: 20527883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
    Radestock S; Weil T; Renner S
    J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virtual high-throughput screening of molecular databases.
    Seifert MH; Kraus J; Kramer B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):298-307. PubMed ID: 17554856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
    Kellenberger E; Foata N; Rognan D
    J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based virtual screening protocols.
    Good A
    Curr Opin Drug Discov Devel; 2001 May; 4(3):301-7. PubMed ID: 11560062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
    Schlosser J; Rarey M
    J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Critical comparison of virtual screening methods against the MUV data set.
    Tiikkainen P; Markt P; Wolber G; Kirchmair J; Distinto S; Poso A; Kallioniemi O
    J Chem Inf Model; 2009 Oct; 49(10):2168-78. PubMed ID: 19799417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.